Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study

OBJECTIVE: To describe the real‐world treatment persistence (defined as the continuation of medication for the prescribed treatment duration), demographics and clinical characteristics, and treatment patterns for patients prescribed erenumab for migraine prevention in Canada. BACKGROUND: The effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gladstone, Jonathan, Chhibber, Sameer, Minhas, Jagdeep, Neish, Calum S., Power, G. Sarah, Lan, Zhiyi, Rochdi, Driss, Lanthier‐Martel, Jessica, Bastien, Natacha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298790/
https://www.ncbi.nlm.nih.gov/pubmed/34807454
http://dx.doi.org/10.1111/head.14218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298790/
https://www.ncbi.nlm.nih.gov/pubmed/34807454
http://dx.doi.org/10.1111/head.14218

Ejemplares similares